Medicine and Dentistry
Disease
100%
Neoplasm
85%
Dermatology
71%
Nodular Melanoma
65%
Dermatosis
59%
Mohs Surgery
48%
Morphea
44%
Neurofibromatosis Type I
42%
Plexiform Neurofibroma
39%
Cicatricial Pemphigoid
38%
Human Immunodeficiency Virus
37%
Kalinin
34%
Diagnosis
29%
Malignant Neoplasm
29%
Human Immunodeficiency Virus Infection
26%
Skin Cancer
24%
Biopsy
24%
Clinical Feature
23%
Squamous Cell Carcinoma
23%
Cancer
23%
Metastatic Carcinoma
22%
Systematic Review
22%
Psoriasis
21%
Quality of Life
21%
Autoantibodies
20%
Keratinocyte
20%
Infection
19%
Dermatological Agent
19%
Acneiform Eruption
19%
Subacute Cutaneous Lupus Erythematosus
18%
Atopic Dermatitis
17%
Clinician
17%
Papule
16%
Pediatrics
16%
Skin Surgery
16%
Basal-Cell Carcinoma
16%
Cross Sectional Study
16%
Symptom
15%
Stevens-Johnson Syndrome
15%
Toxic Epidermal Necrolysis
15%
Phototherapy
15%
Systemic Lupus Erythematosus
15%
Discoid Lupus Erythematosus
14%
Scar Formation
14%
Pigmented Lesion
14%
Bullous Pemphigoid
14%
Basement Membrane
14%
Chloasma
14%
Dermatitis
14%
Carcinogenesis
14%
Pediatrics Patient
14%
Recurrent Disease
13%
Drug Therapy
13%
Skin Carcinoma
13%
Actinic Keratosis
13%
Skin Defect
13%
Neck
12%
Cutaneous Melanoma
12%
Kaposi Sarcoma
12%
Hyperpigmentation
12%
Combination Therapy
11%
Keloid
11%
Cosmetics
11%
Adverse Event
11%
Bacillary Angiomatosis
11%
Epidermolysis bullosa
10%
Acquired Immune Deficiency Syndrome
10%
Lupus Erythematosus
10%
Radiation Therapy
10%
Dysplastic Nevus Syndrome
10%
Pruritus
10%
Non Melanoma Skin Cancer
10%
Histopathology
10%
Virus Infection
10%
Differential Diagnosis
10%
Tumor Cell
10%
Clinical Trial
10%
Awareness
9%
Teledermatology
9%
Erythema
9%
Injury
9%
Lichen Planus
9%
Blister
9%
Melanocyte
9%
Surgery
9%
Surgeon
9%
Immunosuppressive Treatment
8%
Prevalence
8%
Disease Activity
8%
Gene Expression
8%
Scleroderma
8%
Retrospective Cohort Study
8%
Health Care Cost
8%
Cohort Effect
8%
Lip
8%
Disease Course
7%
Malignant Peripheral Nerve Sheath Tumor
7%
Lymphocyte
7%
Sequela
7%
Bowen's Disease
7%
Immunology and Microbiology
Autoantibodies
59%
Cicatricial Pemphigoid
47%
Bullous Pemphigoid
40%
Laminin
33%
Keratinocyte
30%
Basement Membrane
27%
Human Immunodeficiency Virus
24%
Human Immunodeficiency Virus Infection
24%
Morphea
22%
Mouse
18%
T Cell
17%
Immunofluorescence
16%
Complement Component 5a
16%
Dermatitis
15%
Normal Human
13%
Monospecific Antibody
13%
Lupus Erythematosus
13%
Immune Complex
11%
interferon
11%
Lupus Erythematosus
10%
Macrophage
10%
Cytokine
10%
Systemic Lupus Erythematosus
10%
Immune Response
10%
Pemphigoid
10%
Autoantigen
9%
Immunoglobulin A
9%
Leukocyte
9%
Complement Component C5a [Dearginine]
9%
Telomere
8%
B Cell
8%
Wart Virus
8%
Autoimmune Disease
8%
Carboxy Terminal Sequence
7%
Complement Component C3d
7%
Hair Follicle
7%
Immunoprecipitation
7%
Atopic Dermatitis
7%
Immunosuppression
7%
Western Blot
7%
Serum Sickness
6%
Lymphocyte
6%
Fibroblast
6%
Squamous Cell
6%
Autoimmunity
6%
Langerhans Cell
6%
Mucosa
6%
Lamina Densa
6%
Cell Surface
6%
Neutrophil Granulocyte
5%
Immunodeficiency
5%
Basement Membrane Antibody
5%
Neutrophil
5%
Prevalence
5%
Scar Formation
5%
TLR 1
5%
Lamina Lucida
5%
Herpesviridae
5%
Saccharomyces cerevisiae
5%
Cell Adhesion Molecule
5%
Monocyte
5%
Keyphrases
Cicatricial Pemphigoid
28%
Neurofibromatosis Type 1 (NF-1)
26%
Mohs Micrographic Surgery
25%
Neurofibromatosis Type I
22%
Autoantibodies
19%
Dermatologist
18%
Laminin α5
16%
Tumor
16%
Cutaneous Lupus Erythematosus
15%
Clinical Features
15%
Neurofibroma
14%
Skin Cancer
14%
Melanoma
13%
Skin Diseases
12%
IgG Autoantibodies
11%
Bullous Pemphigoid
11%
Tumorigenesis
11%
Morphea
11%
Actinic Keratosis
11%
Epidermis
10%
Basal Cell Carcinoma
10%
Cutaneous Manifestations
10%
Histopathological Features
9%
HIV Infection
9%
Squamous Cell Carcinoma (SqCC)
9%
Microenvironment
9%
United States
9%
Discoid Lupus Erythematosus
9%
Nodule
9%
AIDS/HIV
9%
Kaposi Sarcoma
8%
Cutaneous Neurofibroma
8%
Melanocytic Nevus
8%
Epidermal Basement Membrane
7%
Autoimmune Blistering Diseases
7%
Cutaneous Squamous Cell Carcinoma (cSCC)
7%
Quality of Life
7%
Retrospective Cohort Study
7%
Autoimmune
7%
Melanoma in Situ
7%
Papules
7%
Psoriasis
7%
Neoplasms
6%
Histologic
6%
Single Institution
6%
Malignancy
6%
National Psoriasis Foundation
6%
Epidermolysis Bullosa Acquisita
6%
Dysplastic Nevus
6%
Systemic Disease
6%
Endothelial Cells
6%
Melasma
6%
Cutaneous Lymphoma
6%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
6%
Human Immunodeficiency Virus Infection
6%
Clinical Outcomes
5%
Glucose Transporter 1 (GLUT1)
5%
HIV Patients
5%
Bullous Pemphigoid Antigen
5%
Treatment Options
5%
Dermatopathology
5%
Non-melanoma Skin Cancer
5%
Inflammatory Skin Diseases
5%
Macrophages
5%
Risk Factors
5%
Psoriatic Arthritis
5%
COL17A1
5%
Normal Human
5%
Keratinocytes
5%
Human Keratinocytes (HaCaT)
5%
Benign Tumor
5%
Type XVII Collagen
5%
Skin Lesions
5%
Systemic Lupus Erythematosus
5%
Type VII Collagen
5%
Pemphigoid
5%